Friday, May 9, 2025
5/9/2025
GENE EXPRESSION IN ENTAMOEBA HISTOLYTICA - DESCRIPTION (provided by the applicant): We propose to study gene expression in Entamoeba histolytica controlled by the upstream regulatory element 3 binding protein (URE3-BP). We hypothesize that URE3-BP regulates virulence by a coordinated regulation of.qene expression in response to changes in intracellular Ca 2*. This sequence-specific DNA binding protein recognizes the URE3 sequence present in the promoters of the Gal/GalNAc-inhibitible lectin hgl5 and ferredoxin 1 fdx genes. URE3-BP contains two Ca2*-binding EF-hand motifs, and increases in Ca 2v block its ability to bind to URE3 in vitro and to URE3-containing promoters in vivo. Mutation of the second EF hand motif in URE3-BP leads to a loss of Ca 2. inhibition of DNA binding. These results demonstrate that elevated intracellular Ca 2vblocks the ability of URE3-BP to bind to URE3-containing promoters. Modulation of URE3-BP by intracellular Ca 2v may represent an important mechanism of control of gene expression in E. histolytica. Three specific aims are proposed to test our hypothesis: (1) Study of the URE3-BP - URE3 cisacting DNA sequence interaction, including definition of the DNA motif required for the interaction as determined by experimental and computer-assisted modeling; (2) Study of the structure and function of URE3-BP, including mapping residues important in binding to calcium, DNA and membranes as well as domains of the molecule important for intracellular localization; and (3) Determination of gene expression controlled by URE3-BP, including Entamoeba genomic micro-array analysis of global gene expression and chromatin immunoprecipitation using anti-URE3-BP mAb. Successful completion of these studies will provide insight into transcription regulation of virulence factors by the novel mechanism of direct calcium control of an EF-hand containing transcription factor.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).